Glycyrrhizin, a direct HMGB1 inhibitor, suppresses NHEJ repair, induces DNA damage, restores caspase-3 activation, and triggers apoptosis in colorectal cancer models [38], illustrating the therapeutic value of targeting the HMGB1-driven survival network. Here, HMGB1 is linked to colorectal cancer.